The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic Renal Cancer.

Collinson, FJ, Gregory, WM, McCabe, C et al. (11 more authors) (2012) The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic Renal Cancer. BMC Cancer, 12. 598 - ? . ISSN 1471-2407

Abstract

Metadata

Authors/Creators:
  • Collinson, FJ
  • Gregory, WM
  • McCabe, C
  • Howard, H
  • Lowe, C
  • Potrata, D
  • Tubeuf, S
  • Hanlon, P
  • McParland, L
  • Wah, T
  • Selby, PJ
  • Hewison, J
  • Brown, J
  • Brown, J
Copyright, Publisher and Additional Information: © 2012 Collinson et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Dates:
  • Published: 2012
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Academic Unit of Health Economics (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 22 Mar 2013 12:08
Last Modified: 27 Oct 2016 06:19
Published Version: http://dx.doi.org/10.1186/1471-2407-12-598
Status: Published
Publisher: Biomed Central
Identification Number: https://doi.org/10.1186/1471-2407-12-598
Related URLs:

Share / Export

Statistics